Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% vs 10% Potassium Hydroxide for Molluscum Contagiosum
NCT05634460Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of potassium hydroxide in molluscum contagiosum (MC) (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Efficacy (Lesion Clearance) at 6 months. Started Mar 2022; status: completed.
02
Drugs
potassium hydroxide
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT05634460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634460.